BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsHighNeutral
Announced Sat, 23 May · 23:11 IST

Bliss GVS Pharma Limited has informed the Exchange about Agreements

Promoter Stake Sell 1pctOwnership Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+26.6%1-day move
₹301.00
prior close
₹322.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.3-3.9-4.4-4.9+26.6+31.9+41.0+33.7+44.8+50.6+51.1+63.3+51.7
Up moveDown movePending
AI summary

Anupam Rasayan India Limited has entered into a Share Purchase Agreement to acquire 43.30% (4,58,03,024 shares) of Bliss GVS Pharma Limited from existing shareholders. The promoter group (Mr. Narsimha Kamath, Dr. Vibha Sharma, Ms. Shruti Rao) is selling 31.59% of their stake, while non-promoter shareholders (Mr. Gautam Ashra, Mr. Arjun Ashra, and Gulbarga Trading) are selling 11.70%. The deal is valued at ₹1,369.51 crore (₹299 per share). Following this acquisition, Anupam Rasayan India Limited will become the new promoter and take control of the company. A mandatory open offer under SEBI Takeover Regulations has been triggered for 26% of the total paid-up equity capital. Sellers may retain a residual 4.90% stake (51,81,571 shares) which the purchaser has an option to acquire later.

Likely market impact

This is a major change of control transaction that will replace the existing promoter group with Anupam Rasayan India Limited. Existing shareholders should monitor the open offer process as the new acquirer gains majority control.